Monday, 25 February 2019

Reuters Health Report: Roche 'steps up' for gene therapy with $4.3 billion Spark bet

Reuters.com Newsletter

Roche 'steps up' for gene therapy with $4.3 billion Spark bet

Roche is buying U.S.-based gene therapy specialist Spark Therapeutics for $4.3 billion after developments in this area convinced the Swiss drugmaker to "step up", Chief Executive Severin Schwan said on Monday.

Novartis aims to pump up cardio business with Ionis deal

Novartis on Monday exercised its option to license an RNA-targeting cardiovascular drug from Ionis Pharmaceuticals as the Swiss company aims to surround its heart-failure blockbuster Entresto with other medicines.

Ipsen to buy Clementia Pharmaceuticals in deal worth up to $1.3 billion

French healthcare company Ipsen has agreed to buy U.S. peer Clementia Pharmaceuticals in a deal worth up to $1.31 billion, the companies said on Monday, helping to boost Ipsen's portfolio of products treating rare diseases.

African swine fever spreads to fourth Vietnamese province: state media

African swine fever is spreading in Vietnam hitting two more provinces, after it was first detected in three separate farms in two other provinces earlier this month.

African swine fever spreads to fourth Vietnamese province: state media

African swine fever has spread to Thanh Hoa province, south of Hanoi, the fourth Vietnamese province to report infections, state media said on Monday.

Court ruling could help J&J defeat St. Louis talc lawsuits

A Missouri Supreme Court ruling on talc lawsuits could reduce the liability and number of large trials Johnson & Johnson faces over allegations its talc products, including baby powder, cause cancer.

Japan scientists win backing for work on potential Nipah vaccine

A global coalition set up to fight emerging epidemics has struck a $31 million deal with scientists at Japan's University of Tokyo to speed up work on a vaccine against a brain-damaging disease caused by the Nipah virus.

Bayer faces second trial over alleged Roundup cancer risk

Bayer AG is set to face a second U.S. jury over allegations that its popular glyphosate-based weed killer Roundup causes cancer, six months after the company's share price was rocked by a $289 million verdict in California state court.

China reports two new African swine fever outbreaks

China on Sunday confirmed two new outbreaks of African swine fever, one in the northern province of Hebei and the other in the northern region of Inner Mongolia, as the highly contagious disease spreads through the world's largest hog herd.

United States charges man accused in leak of Singapore HIV data

Authorities in the United States have charged a man accused of leaking information on thousands of HIV victims in Singapore with possession and unlawful transfer of stolen documents.

Novartis gene therapy would be cost effective up to $900,000: U.S. group

An experimental gene therapy for spinal muscular atrophy (SMA) developed by Novartis AG would be worth up to $900,000, according to an independent U.S. nonprofit organization that reviews the value of drugs and medical treatments.

Related Videos

'Green Book' nabs best picture at the Oscars

R. Kelly charged with 10 counts sex abuse

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS